| Code | Display | Definition |
| DE40 | Number of doses per vial | The number of doses contained within a vial |
| DE41 | Initial balance | The initial quantity of vials in stock at the beginning of a specific reporting period |
| DE42 | Closing balance | The quantity of vials in stock at the end of a specific reporting period |
| DE43 | Administered doses | The quantity of vials that have been administered to clients during a specified time frame |
| DE44 | Stock opened | The quantity of vials that were opened during a specific period |
| DE45 | Stock received | The quantity of vials that have been received from external sources, such as suppliers, during a specific period |
| DE46 | Physical count adjustment | An adjustment made to the stock level to correct discrepancies between the recorded inventory and the actual physical count, which may be necessary owing to errors, theft or other discrepancies |
| DE47 | Closed stock discarded | The quantity of vials that were not opened and have been wasted or discarded, owing to expiration or other reasons, during a specific period |
| DE48 | Closed stock discarded type | Specific reason for the disposal of vaccine |
| DE49 | Broken/damaged | The vaccine is physically damaged or broken, rendering it unsuitable for use |
| DE50 | Expired product | The vaccine has reached its expiration date and is no longer safe or effective for use |
| DE51 | Cold storage malfunction | There has been a malfunction or failure in the cold storage equipment, which has led to the degradation of the vaccine |
| DE52 | Vaccine vial monitor status change | The vaccine vial monitor has indicated a change in status, possibly indicating that the vaccines may no longer be viable |
| DE53 | Frozen | The vaccine has been exposed to freezing temperatures, making it unsuitable for use as freezing can affect the integrity and efficacy of certain immunization products |
| DE18 | Report subject area | Location (vaccination location or place) for which the data in the report are being represented |
| DE20 | Reporting period start date | The start date of the reporting period for which data in the report have been included |
| DE21 | Reporting period end date | The end date of the reporting period for which data in the report have been included |
| DE30 | Disaggregation group | Indicates the overall strata or disaggregation represented in the report (e.g. by gender, by region, by age group, etc.) |
| DE31 | By-Sex | A disaggregation grouped by the indicator population's sex values |
| DE32 | By-Administrative Area | A disaggregation grouped by the indicator population's administrative regions/areas |
| DE33 | By-Age group | A disaggregation grouped by the indicator population's age groups |
| DE34 | By-Dose number | A disaggregation grouped by the indicator population's dose numbers for a specific vaccine |
| DE35 | By-Vaccine type | A disaggregation grouped by the indicator population's vaccine types |
| DE36 | By-Vaccine manufacturer | A disaggregation grouped by the indicator population's vaccine manufacturers for a specific vaccine |
| DE37 | By-Reaction manifestation | A disaggregation grouped by the indicator population's reaction manifestations for a specific vaccine |
| DE39 | By-Type of reaction | A disaggregation grouped by the indicator population's type of reaction for a specific vaccine |
| DE54 | By-Risk and occupational group | A disaggregation grouped by the indicator population's risk and occupational group |